Company

Mauna Kea Technologies SA

Headquarters: Paris, France

Employees: 99

Market Cap

€28.9 Million

EUR as of Jan. 1, 2024

US$32.0 Million

Market Cap History

Mauna Kea Technologies SA market capitalization over time

Evolution of Mauna Kea Technologies SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Mauna Kea Technologies SA

Detailed Description

Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Mauna Kea Technologies SA has the following listings and related stock indices.


Stock: FSX: 1MK wb_incandescent

Stock: Euronext: MKEA wb_incandescent

Details

Headquarters:

9, rue d'Enghien

Paris, 75010

France

Phone: 33 1 48 24 03 45

Fax: 33 1 48 24 12 18